Prevalence, risk factors, and management of asthma in China: a national cross-sectional study

The Lancet

Volumn 394, Issue 10196, 2019, Pages 407-418

  Huang, Kewu ^a,b   Yang, Ting ^c,d,e,g   Xu, Jianying ^h   Yang, Lan ⁱ   Zhao, Jianping ^j   Zhang, Xiangyan ^c,d,e,g   Bai, Chunxue ^l   Kang, Jian ^m   Ran, Pixin ⁿ   Shen, Huahao ^o   Wen, Fuqiang ^p   Chen, Yahong ^q   Sun, Tieying ^r   Shan, Guangliang ^s   Lin, Yingxiang ^a,b   Xu, Guodong ^c   Wu, Sinan ^c,d,e   Wang, Chaolong ^j   Wang, Ruiying ^h   Shi, Zhihong ⁱ   Xu, Yongjian ^j   Ye, Xianwei ^k   Song, Yuanlin ^l   Wang, Qiuyue ^m   Zhou, Yumin ⁿ   Li, Wen ^o   Ding, Liren ^o   Wan, Chun ^p   Yao, Wanzhen ^q   Guo, Yanfei ^r   Xiao, Fei ^r   Lu, Yong ^a,b   Peng, Xiaoxia ^t   Zhang, Biao ^s   Xiao, Dan ^c,d,e,f   Wang, Zuomin ^a   Chen, Zhengming ^u   Bu, Xiaoning ^a,b   Zhang, Hong ^a,b   Zhang, Xiaolei ^k   An, Li ^a,b   Zhang, Shu ^a,b   Zhu, Jianguo ^r   Cao, Zhixin ^a,b   Zhan, Qingyuan ^c,d,e,g   Yang, Yuanhua ^a,b   Liang, Lirong ^a,b   Tong, Xunliang ^r   Dai, Huaping ^c,d,e,g   Cao, Bin ^c,d,e,g   Wu, Tangchun ^j   Chung, Kian Fan ^v   He, Jiang ^w   Wang, Chen ^c,d,e,f,g   more..

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Institute of Respiratory Medicine   (China)

^c CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^d PEKING UNION MEDICAL COLLEGE   (China)

^e Center of Respiratory Medicine   (China)

^f WHO Collaborating Centre for Tobacco Cessation and Respiratory Diseases Prevention   (China)

^g CAPITAL MEDICAL UNIVERSITY   (China)

^h Shanxi Dayi Hospital   (China)

ⁱ THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^j HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^k GUIZHOU PROVINCIAL PEOPLE'S HOSPITAL   (China)

^l FUDAN UNIVERSITY   (China)

^m CHINA MEDICAL UNIVERSITY   (China)

ⁿ GUANGZHOU MEDICAL UNIVERSITY   (China)

^o THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^p SICHUAN UNIVERSITY   (China)

^q PEKING UNIVERSITY THIRD HOSPITAL   (China)

^r BEIJING HOSPITAL   (China)

^s INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^t CAPITAL MEDICAL UNIVERSITY   (China)

^u UNIVERSITY OF OXFORD   (United Kingdom)

^v ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^w TULANE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; SALBUTAMOL;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BRONCHITIS; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE BURDEN; DISEASE EXACERBATION; EDUCATIONAL STATUS; FEMALE; HOSPITAL ADMISSION; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SMOKING; WHEEZING; CIGARETTE SMOKING; COMPLICATION; DISEASE MANAGEMENT; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; BRONCHITIS; CHINA; CIGARETTE SMOKING; CROSS-SECTIONAL STUDIES; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PREVALENCE; RHINITIS, ALLERGIC; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 85069903842     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(19)31147-X     Document Type: Article

References (43)

1. GINA Executive and Science committee. Global strategy for asthma management and prevention. http://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/wms-GINA-2018-report-V1.3-002.pdf, 2018. (Accessed 20 December 2018)
2. GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med 5 (2017), 691–706.
3. Masoli, M, Fabian, D, Holt, S, Beasley, R, Global Initiative for Asthma P. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59 (2004), 469–478.
4. To, T, Stanojevic, S, Moores, G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health, 12, 2012, 204.
5. Lin, Y, Wang, C, Lin, J, et al. Epidemiological survey of the incidence of bronchial asthma in occupational populations in Beijing area. Chin J Tuber Respir Dis 25 (2002), 650–654 (in Chinese).
6. Wang, DX, Xiao, W, Ma, DD, et al. Cross-sectional epidemiological survey of asthma in Jinan, China. Respirology 18 (2013), 313–322.
7. Chan-Yeung, M, Zhang, LX, Tu, DH, et al. The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China. Eur Respir J 19 (2002), 853–858.
8. Wu, F, Guo, Y, Kowal, P, et al. Prevalence of major chronic conditions among older Chinese adults: the Study on Global AGEing and adult health (SAGE) wave 1. PLoS One, 8, 2013, e74176.
9. Lin, J, Wang, W, Chen, P, et al. Prevalence and risk factors of asthma in mainland China: the CARE study. Respir Med 137 (2018), 48–54.
10. Wang, XD, Zheng, M, Lou, HF, et al. An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011. Allergy 71 (2016), 1170–1180.
11. Postma, DS, Rabe, KF, The asthma-COPD overlap syndrome. N Engl J Med 373 (2015), 1241–1249.
12. Wang, C, Xu, J, Yang, L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet 391 (2018), 1706–1717.
13. National Bureau of Statistics of China. 2010 Population Census. http://www.stats.gov.cn/english/StatisticaldataCensusData/, 2013. (Accessed 3 April 2018)
14. de Marco, R, Zanolin, ME, Accordini, S, et al. A new questionnaire for the repeat of the first stage of the European Community Respiratory Health Survey: a pilot study. Eur Respir J 14 (1999), 1044–1048.
15. Han, J, Zhu, Y, Li, S, et al. Respiratory complaints in Chinese: cultural and diagnostic specificities. Chest 127 (2005), 1942–1951.
16. Miller, MR, Hankinson, J, Brusasco, V, et al. Standardisation of spirometry. Eur Respir J 26 (2005), 319–338.
17. Vogelmeier, CF, Criner, GJ, Martinez, FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 report. GOLD Executive Summary. Am J Respir Crit Care Med 195 (2017), 557–582.
18. Jian, W, Gao, Y, Hao, C, et al. Reference values for spirometry in Chinese aged 4–80 years. J Thorac Dis 9 (2017), 4538–4549.
19. Bousquet, J, Khaltaev, N, Cruz, AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63:suppl 86 (2008), 8–160.
20. Ware, JE Jr, Kosinski, M, Keller, SD, A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34 (1996), 220–233.
21. Lee, ES, Forthofer, RN, The Taylor series method (Linearization). Lee, ES, Forthofer, RN, (eds.) Analyzing complex survey data, 2005, Sage Publications, Thousand Oaks, CA, 36–39.
22. National Bureau of Statistics of China. 2016 China statistical yearbook. http://www.stats.gov.cn/tjsj/ndsj/2016/indexeh.htm, 2016. (Accessed 3 April 2018)
23. Barjaktarevic, I, Kaner, R, Buhr, RG, Cooper, CB, Bronchodilator responsiveness or reversibility in asthma and COPD—a need for clarity. Int J Chron Obstruct Pulmon Dis 13 (2018), 3511–3513.
24. Fukutomi, Y, Nakamura, H, Kobayashi, F, et al. Nationwide cross-sectional population-based study on the prevalences of asthma and asthma symptoms among Japanese adults. Int Arch Allergy Immunol 153 (2010), 280–287.
25. Morgan, BW, Grigsby, MR, Siddharthan, T, et al. Epidemiology and risk factors of asthma-chronic obstructive pulmonary disease overlap in low- and middle-income countries. J Allergy Clin Immunol 143 (2019), 1598–1606.
26. Henriksen, AH, Langhammer, A, Steinshamn, S, Mai, XM, Brumpton, BM, The prevalence and symptom profile of asthma-COPD overlap: the HUNT study. COPD 15 (2018), 27–35.
27. de Marco, R, Marcon, A, Rossi, A, et al. Asthma, COPD and overlap syndrome: a longitudinal study in young European adults. Eur Respir J 46 (2015), 671–679.
28. Kim, YK, Kim, SH, Tak, YJ, et al. High prevalence of current asthma and active smoking effect among the elderly. Clin Exp Allergy 32 (2002), 1706–1712.
29. Skloot, GS, Busse, PJ, Braman, SS, et al. An Official American Thoracic Society Workshop report: evaluation and management of asthma in the elderly. Ann Am Thorac Soc 13 (2016), 2064–2077.
30. Platts-Mills, TA, The allergy epidemics: 1870–2010. J Allergy Clin Immunol 136 (2015), 3–13.
31. Wang, YC, Jaakkola, MS, Lajunen, TK, Lai, CH, Jaakkola, JJK, Asthma-COPD overlap syndrome among subjects with newly diagnosed adult-onset asthma. Allergy 73 (2018), 1554–1557.
32. Diette, GB, Accinelli, RA, Balmes, JR, et al. Obstructive lung disease and exposure to burning biomass fuel in the indoor environment. Glob Heart 7 (2012), 265–270.
33. Gaviola, C, Miele, CH, Wise, RA, et al. Urbanisation but not biomass fuel smoke exposure is associated with asthma prevalence in four resource-limited settings. Thorax 71 (2016), 154–160.
34. Doiron, D, de Hoogh, K, Probst-Hensch, N, et al. Residential air pollution and associations with wheeze and shortness of breath in adults: a combined analysis of cross-sectional data from two large European cohorts. Environ Health Perspect, 125, 2017, 097025.
35. Gunnbjornsdottir, MI, Franklin, KA, Norback, D, et al. Prevalence and incidence of respiratory symptoms in relation to indoor dampness: the RHINE study. Thorax 61 (2006), 221–225.
36. Anto, JM, Sunyer, J, Basagana, X, et al. Risk factors of new-onset asthma in adults: a population-based international cohort study. Allergy 65 (2010), 1021–1030.
37. Fazlollahi, MR, Najmi, M, Fallahnezhad, M, et al. The prevalence of asthma in Iranian adults: the first national survey and the most recent updates. Clin Respir J 12 (2018), 1872–1881.
38. Kumar, P, Ram, U, Patterns, factors associated and morbidity burden of asthma in India. PLoS One, 12, 2017, e0185938.
39. Janson, C, Chinn, S, Jarvis, D, Burney, P, Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J 10 (1997), 1795–1802.
40. Suruki, RY, Daugherty, JB, Boudiaf, N, Albers, FC, The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC Pulm Med, 17, 2017, 74.
41. Lai, K, Chen, R, Lin, J, et al. A prospective, multicenter survey on causes of chronic cough in China. Chest 143 (2013), 613–620.
42. Lai, K, Pan, J, Chen, R, Liu, B, Luo, W, Zhong, N, Epidemiology of cough in relation to China. Cough, 9, 2013, 18.
43. The State Council of the People's Republic of China. Chinese Medium-to-Long-term Plan for Chronic Disease Prevention and Control (2017–2025). http://www.gov.cn/zhengce/content/2017-02/14/content_5167886.htm. (Accessed 8 June 2019)